SESSION TITLE: Sleep Disorders 2
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Adaptive Servo Ventilation (ASV) is a therapy intended for adults with Central Sleep Apnea (CSA) and Complex Sleep Apnea (Complex-SA). Central sleep apnea, specifically narcotic-induced central sleep apnea (NICSA) and CSA associated with congestive heart failure (CHF), have been studied with ASV treatment on a limited basis. There are recent reports of increased cardiac mortality with the use of ASV theraphy for CSA in those with CHF who are slightly to greatly impaired (>NYHA class I). Our aim is to report one sleep centers experience with our patients with CSA who underwent ASV titration and to examine mortality amongst all patients and specifically those with CHF, narcotic and other forms of central sleep apnea.